Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life
and longevity. The epidemiology of VHD varies substantially around the world, with a …

Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Background: Historical data suggesting poor survival in patients with aortic stenosis (AS)
who do not undergo treatment are largely confined to patients with severe AS. Objectives …

731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Background The clinical course of patients with moderate aortic stenosis (AS) remains
incompletely defined. Objectives This study sought to analyze the clinical course of …

Valvular heart disease is a leading cause of cardiovascular morbidity and mortality and a
major contributor of symptoms and functional disability. Knowledge of valvular heart disease …

Background Although women represent half of the population burden of aortic stenosis (AS),
little is known whether sex affects the presentation, management, and outcome of patients …

Current guidelines recommend that clinical surveillance for patients with moderate aortic
stenosis (AS) and aortic valve replacement (AVR) may be considered if there is an indication …

This review discusses the evolving topic of atrial cardiomyopathy concerning valvular heart
disease. The pathogenesis of atrial cardiomyopathy involves multiple factors, such as …

Importance Modern data regarding incidence and modes of death of patients with aortic
stenosis (AS) are restricted to tertiary centers or studies of aortic valve replacement (AVR) …